Onilcamotide
Onilcamotide (RV001) is a C-terminal peptide of RhoC protein. Onilcamotide is a cancer vaccine and has potential immunomodulating and antineoplastic activities[1].
Product Specifications
CAS Number
1164096-85-8
Product Name Alternative
RV001
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/onilcamotide.html
Solubility
10 mM in DMSO
Smiles
CC(C)C[C@@H](C(O)=O)NC([C@H]([C@@H](C)CC)NC([C@H]1N(CCC1)C([C@H](CS)NC(CNC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC([C@H](CC(N)=O)NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC([C@H](CCC(N)=O)NC([C@H](CC(C)C)NC(CNC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@H]([C@H](O)C)NC([C@@H](N)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C96H177N39O24S
Molecular Weight
2293.75
References & Citations
[1]Schuhmacher J, et al. Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial. J Immunother Cancer. 2020;8 (2) :e001157.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6227559-01 0.1 mL
FLI1 (Friend Leukemia Virus Integration 1, EWSR2, SIC-1) (MaxLight 650)
Sign In for Pricing
View Details MBS6227559-02 5x 0.1 mL
FLI1 (Friend Leukemia Virus Integration 1, EWSR2, SIC-1) (MaxLight 650)
Sign In for Pricing
View Details 
